EMA Authorised: Iscover (clopidogrel) — Sanofi Winthrop Industrie

View source ↗

Summary

The European Medicines Agency has authorised Iscover, a clopidogrel product from Sanofi Winthrop Industrie, for preventing thrombotic events in conditions such …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome
• Myocardial Infarction
• Peripheral Vascular Disease
• Stroke

Drugs mentioned

• Iscover (clopidogrel)

Snippet

Status: Authorised. Therapeutic area: Stroke;Peripheral Vascular Diseases;Atrial Fibrillation;Myocardial Infarction;Acute Coronary Syndrome. MAH: Sanofi Winthrop Industrie. Decision date: 26/08/2025